PMID- 22561999 OWN - NLM STAT- MEDLINE DCOM- 20120719 LR - 20120507 IS - 1473-6527 (Electronic) IS - 0951-7375 (Linking) VI - 25 IP - 3 DP - 2012 Jun TI - The burden of nonencapsulated Haemophilus influenzae in children and potential for prevention. PG - 266-72 LID - 10.1097/QCO.0b013e32835310a4 [doi] AB - PURPOSE OF REVIEW: In countries with established Haemophilus influenzae serotype b (Hib) immunization programmes, nonencapsulated H. influenzae (ncHi) is responsible for most invasive H. influenzae infections across all age groups and is associated with higher case fatality. A pneumococcal conjugate vaccine has recently been licensed, which may potentially also protect against invasive H. influenzae infections. RECENT FINDINGS: Invasive ncHi disease is uncommon in childhood but has a much higher incidence in the first month of life. Most neonates with invasive ncHi infections are born prematurely and develop septicaemia in the first 48 h of life which can be fatal. After this period, invasive ncHi incidence falls rapidly and remains low throughout childhood. Most infants and children who develop invasive ncHi disease have significant underlying comorbidities, particularly neurological disease, malignancy and other conditions requiring immunosuppressive therapy. Although characteristically associated with respiratory tract infections, at least a quarter of invasive ncHi infections present with meningitis. SUMMARY: A vaccine against ncHi could have an important preventive role in children with comorbidities. Future studies should focus on assessing specific risk factors for neonatal and childhood ncHi disease and long-term outcomes of children with invasive ncHi meningitis. FAU - Gkentzi, Despoina AU - Gkentzi D AD - St. George's University of London, Cranmer Terrace, London, UK. FAU - Slack, Mary P E AU - Slack MP FAU - Ladhani, Shamez N AU - Ladhani SN LA - eng PT - Journal Article PT - Review PL - United States TA - Curr Opin Infect Dis JT - Current opinion in infectious diseases JID - 8809878 RN - 0 (Haemophilus Vaccines) SB - IM MH - Adolescent MH - Child MH - Child, Preschool MH - Haemophilus Infections/epidemiology/*microbiology/*prevention & control MH - Haemophilus Vaccines/*administration & dosage MH - *Haemophilus influenzae/immunology/pathogenicity MH - Haemophilus influenzae type b/immunology/pathogenicity MH - Humans MH - Infant MH - Infant, Newborn MH - Influenza, Human/*microbiology/*prevention & control MH - Risk Factors EDAT- 2012/05/09 06:00 MHDA- 2012/07/20 06:00 CRDT- 2012/05/08 06:00 PHST- 2012/05/08 06:00 [entrez] PHST- 2012/05/09 06:00 [pubmed] PHST- 2012/07/20 06:00 [medline] AID - 00001432-201206000-00006 [pii] AID - 10.1097/QCO.0b013e32835310a4 [doi] PST - ppublish SO - Curr Opin Infect Dis. 2012 Jun;25(3):266-72. doi: 10.1097/QCO.0b013e32835310a4.